HIGHLIGHTS
- who: Luzia S. Sampaio from the Atatu00fcrk University, Turkey have published the Article: Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice, in the Journal: (JOURNAL)
- what: The authors focus on the use of CBM for treatment of these neurodegenerative diseases and the assessment of efficacy, safety, and tolerability of this therapeutic tool in humans. In this study, patients did not show improvements in the Neuropsychiatric Inventory (NPI) scale, therefore no amelioration of agitation, life quality aspects and performance in daily activities was reported (van den Elsen et_al . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.